The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease
Silvana‐Yanina Romero‐Zerbo(Instituto de Investigación Biomédica de Málaga), Francisco J. Bermúdez‐Silva(Instituto de Investigación Biomédica de Málaga), Estrella Lara(Instituto de Investigación Biomédica de Málaga), Isabel González‐Mariscal(Inserm), Alejandro Escamilla(Andalusian Centre for Nanomedicine and Biotechnology), Gabriel Olveira(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), Alex Rafacho(Universidade Federal de Santa Catarina), Gemma Rojo‐Martínez(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), Macarena Pozo‐Morales(Université Libre de Bruxelles), Benoit R. Gauthier(University of Geneva), Nadia Cobo‐Vuilleumier(Centro Andaluz de Biología del Desarrollo), Vanesa Espinosa-Jiménez(Hospital Regional Universitario de Málaga), María García‐Fernández(Instituto de Investigación Biomédica de Málaga), Lourdes Sánchez‐Salido(Hospital Regional Universitario de Málaga)
Cited by 31
Related Papers
Pancreatic Insulin Content Regulation by the Estrogen Receptor ERα
|PLoS ONE|2008|398
Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes
|Journal of Endocrinology|2014|214
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
|Journal of Endocrinology|2011|119
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
|Metabolism|2024|111
High doses of dexamethasone induce increased β-cell proliferation in pancreatic rat islets
|American Journal of Physiology-Endocrinology and Metabolism|2009|106